A Study of Giredestrant (GDC-9545) in Postmenopausal Women With Stage I-III Operable, Estrogen Receptor-Positive Breast Cancer
Clinical trial NCT03916744 · COMPLETED
Trial details
- NCT number
- NCT03916744
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-26
- Primary completion
- 2021-05-25
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.